OSPC3_ECOLX
ID OSPC3_ECOLX Reviewed; 484 AA.
AC P0DV36;
DT 23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT 23-FEB-2022, sequence version 1.
DT 03-AUG-2022, entry version 3.
DE RecName: Full=Arginine ADP-riboxanase OspC3 {ECO:0000305};
DE EC=4.3.99.- {ECO:0000269|PubMed:34671164};
GN Name=ospC3 {ECO:0000303|PubMed:34671164};
OS Escherichia coli.
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC Enterobacteriaceae; Escherichia.
OX NCBI_TaxID=562;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=CFSAN029787;
RA Timme R., Allard M.W., Strain E., Evans P.S., Brown E.;
RT "Whole genome shotgun sequencing of cultured foodborne pathogen.";
RL Submitted (MAY-2015) to the EMBL/GenBank/DDBJ databases.
RN [2]
RP FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF GLU-192 AND HIS-328.
RC STRAIN=CFSAN029787;
RX PubMed=34671164; DOI=10.1038/s41586-021-04020-1;
RA Li Z., Liu W., Fu J., Cheng S., Xu Y., Wang Z., Liu X., Shi X., Liu Y.,
RA Qi X., Liu X., Ding J., Shao F.;
RT "Shigella evades pyroptosis by arginine ADP-riboxanation of caspase-11.";
RL Nature 599:290-295(2021).
CC -!- FUNCTION: ADP-riboxanase effector that inhibits host cell pyroptosis
CC (PubMed:34671164). Acts by mediating arginine ADP-riboxanation of host
CC CASP4/CASP11, blocking CASP4/CASP11 autoprocessing (PubMed:34671164).
CC This prevents CASP4 activation and ability to recognize and cleave
CC GSDMD, thereby inhibiting LPS-induced pyroptosis (By similarity). ADP-
CC riboxanation takes place in two steps: OspC3 first catalyzes ADP-
CC ribosylation of target Arg, and then initiates a deamination to remove
CC one N-omega group (By similarity). {ECO:0000250|UniProtKB:A0A0H2US87,
CC ECO:0000269|PubMed:34671164}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=L-arginyl-[protein] + NAD(+) = ADP-riboxanated L-argininyl-
CC [protein] + H(+) + NH4(+) + nicotinamide; Xref=Rhea:RHEA:69500,
CC Rhea:RHEA-COMP:10532, Rhea:RHEA-COMP:17719, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:17154, ChEBI:CHEBI:28938, ChEBI:CHEBI:29965,
CC ChEBI:CHEBI:57540, ChEBI:CHEBI:184300;
CC Evidence={ECO:0000269|PubMed:34671164};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69501;
CC Evidence={ECO:0000269|PubMed:34671164};
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:A0A0H2US87}. Host
CC cytoplasm {ECO:0000250|UniProtKB:A0A0H2US87}. Note=Secreted via the
CC type III secretion system (TTSS). {ECO:0000250|UniProtKB:A0A0H2US87}.
CC -!- SIMILARITY: Belongs to the OspC family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP011417; AKH27395.1; -; Genomic_DNA.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0140740; F:ADP-riboxanase activity; IDA:UniProtKB.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR Gene3D; 1.25.40.20; -; 1.
DR InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR InterPro; IPR010366; OspC1-3.
DR Pfam; PF06128; Shigella_OspC; 1.
PE 1: Evidence at protein level;
KW ANK repeat; Host cytoplasm; Lyase; Repeat; Secreted; Toxin; Virulence.
FT CHAIN 1..484
FT /note="Arginine ADP-riboxanase OspC3"
FT /id="PRO_0000455085"
FT REPEAT 369..398
FT /note="ANK 1"
FT /evidence="ECO:0000255"
FT REPEAT 413..444
FT /note="ANK 2"
FT /evidence="ECO:0000255"
FT REPEAT 451..480
FT /note="ANK 3"
FT /evidence="ECO:0000255"
FT MUTAGEN 192
FT /note="E->A: In EH/AA mutant; abolished arginine ADP-
FT riboxanation of host CASP4/CASP11; when associated with A-
FT 328."
FT /evidence="ECO:0000269|PubMed:34671164"
FT MUTAGEN 328
FT /note="H->A: In EH/AA mutant; abolished arginine ADP-
FT riboxanation of host CASP4/CASP11; when associated with A-
FT 192."
FT /evidence="ECO:0000269|PubMed:34671164"
SQ SEQUENCE 484 AA; 55610 MW; 063E45915DDCA852 CRC64;
MKIPEAVNHI NVQNNIDLVD GKTNPNKATK ALQKNILRVT NSSSSGISEK HLDHCANTVK
NFLRKSIAAQ SYSKMFSQGT SFKSLNLSIE APSGARSSFR SLEHLDKVSR HYISEIIQKV
HPLSSDERLL LSIIINSNFN FRHQSNSNLS NNILNIKSFD KMQSENIQTH KNTYSEDIKE
ISNHDFVFFG VEISNHQEKL PLNKTHHTVD FGANAYIIDH DSPYGYMTLT DHFDNAIPPV
FYHEHQSFFL DNFKEVVDEV SRYVHGNQGK TDVPIFNTKD MRLGIGLHLI DFIRKSKDQG
FREFCYNKNI DPVSLDRIIN FVFQLEYHIP RMLSTDNFKK IKLRDISLED AIKASNYEEI
NNKVTDKKMA HQALAYSLGN KKADIALYLL SKFNFTKQDV AEMEKMNNNR YCNLYDVEYL
LSKDGANYKV LEYFINNGLV DVNKKFQKAN SGDTMLDNAM KSKDSKMIDF LLKNGAILGK
RFEI